Codiak BioSciences Collaborates with Ragon Institute to Evaluate the exoVACC Vaccine Platform in SARS-CoV-2 and HIV Read more
AVEO Oncology announces FDA acceptance for filing of an NDA for Tivozanib as treatment of relapsed or refractory renal cell carcinoma Read more
Lynparza recommended for approval in EU by CHMP for BRCA-mutated metastatic pancreatic cancer Read more
Regeneron and Intellia Therapeutics Expand Collaboration to Develop CRISPR/Cas9-Based Treatments Read more